TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
DRUG

Bright Minds Biosciences Inc

Healthcare · Biotechnology

61.60$ +4.1% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Bright Minds Biosciences Inc (DRUG)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 63.3% of the shares are freely tradable; institutional investors hold 92.8%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 92.8%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 12.0%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 63.3%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 11.8%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 10Mio.

Largest Shareholders

Institutions

Institutions DRUG
Name Stake (%) Shares Change (%) Date
HHG PLC 13.02 1,284,324 +11.1 03/31/2026
Cormorant Asset Management, LLC 10.74 1,059,331 +0.0 03/31/2026
BlackRock Inc 6.31 621,933 +57.8 03/31/2026
Vivo Capital, LLC 5.65 557,172 +0.0 06/30/2026
BRAIDWELL LP 5.47 539,708 +66.4 03/31/2026
Vestal Point Capital LP 4.99 492,319 +0.0 03/31/2026
Driehaus Capital Management LLC 4.38 432,515 +60.4 03/31/2026
Adage Capital Partners Gp LLC 3.40 335,000 -32.4 06/30/2026
Balyasny Asset Management LLC 3.01 297,158 +31.8 03/31/2026
Deerfield Management Co 2.87 283,000 +0.0 03/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?